Jianfeng Zhou

1 clinical trials · Sponsor

Record	Firm	Date
Mitoxantrone Hydrochloride Liposome Combined With Rituximab and Lenalidomide (M+R2) in Patients With Relapsed and Refractory Diffuse Large B-Cell Lymphoma (NCT05575973)	Jianfeng Zhou	2022-10-10

Every clearance here is in the API, with alerts when new ones post.